Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market
Prenetics' IM8 Health has expanded its Scientific Advisory Board (SAB) with the addition of two distinguished members: Dr. Jeremy London, a board-certified cardiothoracic surgeon with 25+ years of experience, and Dr. Amy Shah, a double board-certified expert in Internal Medicine. They join an existing prestigious team from institutions including Mayo Clinic, NASA, Cedars-Sinai, and Yale University.
The expanded SAB supports IM8's flagship product, Daily Ultimate Essentials, a clinically-validated all-in-one daily powder supplement designed to replace up to 16 supplements. The product focuses on energy, immunity, digestion, and longevity, featuring NSF certification for Sport.
This strategic expansion occurs as the global supplements market, currently valued at $152 billion, is projected to reach $300 billion by 2028, driven by increasing demand for scientifically-backed products.
Prenetics' IM8 Health ha ampliato il suo Consiglio Scientifico (SAB) con l'aggiunta di due membri di spicco: Dr. Jeremy London, un chirurgo cardiotoracico certificato con oltre 25 anni di esperienza, e Dr. Amy Shah, un esperto certificato in Medicina Interna. Si uniscono a un prestigioso team già esistente proveniente da istituzioni come la Mayo Clinic, la NASA, Cedars-Sinai e l'Università di Yale.
Il SAB ampliato supporta il prodotto di punta di IM8, Daily Ultimate Essentials, un integratore in polvere quotidiano clinicamente validato progettato per sostituire fino a 16 integratori. Il prodotto si concentra su energia, immunità, digestione e longevità, con certificazione NSF per lo Sport.
Questa espansione strategica avviene mentre il mercato globale degli integratori, attualmente valutato 152 miliardi di dollari, è previsto raggiungere 300 miliardi di dollari entro il 2028, spinto dalla crescente domanda di prodotti supportati scientificamente.
Prenetics' IM8 Health ha ampliado su Consejo Asesor Científico (SAB) con la incorporación de dos miembros distinguidos: Dr. Jeremy London, un cirujano cardiotorácico certificado con más de 25 años de experiencia, y Dr. Amy Shah, una experta certificada en Medicina Interna. Se unen a un equipo prestigioso existente de instituciones como Mayo Clinic, NASA, Cedars-Sinai y la Universidad de Yale.
El SAB ampliado apoya el producto insignia de IM8, Daily Ultimate Essentials, un suplemento diario en polvo clínicamente validado diseñado para reemplazar hasta 16 suplementos. El producto se centra en energía, inmunidad, digestión y longevidad, con certificación NSF para el Deporte.
Esta expansión estratégica ocurre mientras el mercado global de suplementos, actualmente valorado en 152 mil millones de dólares, se proyecta que alcanzará 300 mil millones de dólares para 2028, impulsado por la creciente demanda de productos respaldados científicamente.
Prenetics' IM8 Health는 두 명의 저명한 멤버를 추가하여 과학 자문 위원회(SAB)를 확장했습니다: Dr. Jeremy London, 25년 이상의 경력을 가진 보드 인증 심장 흉부 외과 의사, 그리고 Dr. Amy Shah, 내과 분야의 이중 보드 인증 전문가입니다. 이들은 Mayo Clinic, NASA, Cedars-Sinai, Yale University 등의 기관에서 온 기존의 저명한 팀에 합류합니다.
확대된 SAB는 IM8의 주요 제품인 Daily Ultimate Essentials를 지원합니다. 이 제품은 최대 16개의 보충제를 대체하기 위해 설계된 임상적으로 검증된 올인원 일일 파우더 보충제입니다. 이 제품은 에너지, 면역, 소화 및 장수에 중점을 두며, 스포츠를 위한 NSF 인증을 보유하고 있습니다.
이 전략적 확장은 현재 1,520억 달러로 평가되는 글로벌 보충제 시장이 2028년까지 3,000억 달러에 이를 것으로 예상되는 가운데 이루어집니다. 이는 과학적으로 뒷받침되는 제품에 대한 수요 증가에 의해 촉진됩니다.
Prenetics' IM8 Health a élargi son Conseil Consultatif Scientifique (SAB) avec l'ajout de deux membres distingués : Dr. Jeremy London, un chirurgien cardiothoracique certifié avec plus de 25 ans d'expérience, et Dr. Amy Shah, une experte certifiée en Médecine Interne. Ils rejoignent une équipe prestigieuse déjà existante provenant d'institutions telles que la Mayo Clinic, la NASA, Cedars-Sinai et l'Université de Yale.
Le SAB élargi soutient le produit phare d'IM8, Daily Ultimate Essentials, un complément alimentaire en poudre quotidien cliniquement validé conçu pour remplacer jusqu'à 16 compléments. Le produit se concentre sur l'énergie, l'immunité, la digestion et la longévité, avec une certification NSF pour le Sport.
Cette expansion stratégique intervient alors que le marché mondial des compléments alimentaires, actuellement évalué à 152 milliards de dollars, devrait atteindre 300 milliards de dollars d'ici 2028, soutenue par une demande croissante de produits basés sur des preuves scientifiques.
Prenetics' IM8 Health hat seinen Wissenschaftlichen Beirat (SAB) mit zwei herausragenden Mitgliedern erweitert: Dr. Jeremy London, ein zertifizierter Herz-Thorax-Chirurg mit über 25 Jahren Erfahrung, und Dr. Amy Shah, eine doppelt zertifizierte Expertin für Innere Medizin. Sie treten einem bereits bestehenden, angesehenen Team von Institutionen wie Mayo Clinic, NASA, Cedars-Sinai und Yale University bei.
Der erweiterte SAB unterstützt das Flaggschiffprodukt von IM8, Daily Ultimate Essentials, ein klinisch validiertes All-in-One-Tagespulverpräparat, das bis zu 16 Nahrungsergänzungsmittel ersetzen soll. Das Produkt konzentriert sich auf Energie, Immunität, Verdauung und Langlebigkeit und verfügt über eine NSF-Zertifizierung für Sport.
Diese strategische Expansion erfolgt, während der globale Markt für Nahrungsergänzungsmittel, der derzeit auf 152 Milliarden Dollar geschätzt wird, voraussichtlich bis 2028 auf 300 Milliarden Dollar anwachsen wird, angetrieben durch die steigende Nachfrage nach wissenschaftlich fundierten Produkten.
- Strategic expansion of Scientific Advisory Board with high-profile medical experts
- Strong market growth potential with supplements market projected to reach $300B by 2028
- Flagship product validated through clinical trials and NSF certification
- Prestigious institutional backing from Mayo Clinic, NASA, Yale, and other leading organizations
- None.
Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University
CHARLOTTE, N.C., March 18, 2025 (GLOBE NEWSWIRE) -- IM8, the premium supplements brand co-founded by David Beckham, today announced the addition of two distinguished new members, Dr. Jeremy London and Dr. Amy Shah, to its world-class Scientific Advisory Board (SAB). These additions underscore IM8’s unwavering commitment to leading innovation in science, longevity and human performance.
Newly joining IM8’s SAB are:
Dr. Amy Shah – An acclaimed integrative medicine physician and double board-certified expert in Internal Medicine, Dr. Shah focuses on gut health, hormonal balance and nutrition. Her practical, evidence-based approach and extensive experience in integrative wellness will guide IM8’s continued development of comprehensive wellness solutions.
Dr. Jeremy London – With over 25 years of experience, Dr. London is a board-certified and renowned cardiothoracic surgeon specializing in preventive cardiovascular health. He is recognized as a leader in minimally invasive heart valve treatments and thoracic aortic aneurysm repair. Dr. London’s deep commitment to preventive care and patient education will further enhance IM8’s cardiovascular health product initiatives.
“Our Scientific Advisory Board has been instrumental since day one in helping us set industry-leading standards," said Danny Yeung, co-founding partner and CEO of IM8. “We’re eager to welcome Dr. Jeremy London and Dr. Amy Shah, whose exceptional expertise will elevate our innovative research and product development even further, reinforcing IM8’s position as a trusted leader in health and wellness.”
Since its inception, IM8’s SAB has featured top experts whose contributions have been crucial to the company’s product development. Among those experts include:
Dr. Dawn Mussallem – Integrative Oncologist at Mayo Clinic
Dr. Mussallem is a distinguished consultant in the Division of Hematology Oncology at Mayo Clinic, where she has served as a clinician for over 20 years, and an Assistant Professor of Medicine. She is a double board-certified lifestyle medicine breast specialist at The Robert and Monica Jacoby Center for Breast Health and founded the Integrative Medicine and Breast Health Program at Mayo Clinic Florida.
Dr. Jim Green – Former Chief Scientist of NASA
Dr. Green has led numerous groundbreaking NASA missions, including Mars Rover landings and the New Horizons mission to Pluto. His expertise in space science and biomedical innovations uniquely benefits IM8’s approach to health and longevity.
Dr. James DiNicolantonio – Cardiovascular Research Scientist and Author
Dr. DiNicolantonio is widely recognized for his research on nutrition, metabolism and human health. He is known for translating complex nutritional science into actionable health advice, strengthening IM8’s nutritional offerings. He is the author/co-author of over 250 academic publications in the medical literature spanning nutrition, nutraceuticals, cardiovascular health, longevity and overall health.
Dr. Suzanne Devkota – Director of Microbiome Research Lab at Cedars-Sinai Medical Center
Dr. Devkota’s pioneering research in microbiome science and its role in chronic diseases aligns closely with IM8’s commitment to developing innovative gut-health solutions. With over 15 years of experience in the field, Dr. Devkota’s research emphasizes the critical connection between the microbiome and overall health, highlighting the potential for microbiome-based therapies.
Dr. David Katz – Founding Director of Yale-Griffin Prevention Research Center
Dr. Katz is an internationally recognized expert in preventive medicine, nutrition and public health. His contributions have significantly influenced IM8’s scientifically-validated nutrition and preventive healthcare solutions. He has roughly 250 peer-reviewed publications and has authored/co-authored 19 books to date including multiple editions of leading textbooks in nutrition, preventive medicine, and epidemiology.
Dr. Stephen Anton – Professor in the Department of Physiology and Aging at University of Florida
Prof. Stephen Anton is a renowned expert in aging and metabolic health, with over 20 years of experience in the field. He is a Distinguished Professor at the University of Florida with a primary appointment in the Department of Physiology and Aging. Prof. Anton’s research focuses on the interplay between lifestyle factors, metabolic health, and aging, with a particular emphasis on the benefits of caloric restriction, intermittent fasting, and physical activity.
IM8’s flagship product, Daily Ultimate Essentials, exemplifies the SAB’s foundational role. This clinically-validated all-in-one daily powder supplement is designed to replace up to 16 supplements, enhancing energy, immunity, digestion and longevity. Supported by rigorous clinical trials and third-party NSF certification for Sport, it demonstrates IM8’s dedication to quality, transparency and efficacy.
The global supplements market is valued at
About IM8
IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics, a leading global health sciences company dedicated to advancing consumer health.
Media Contact
Camille Livesay
Jack Taylor Public Relations
im8@jacktaylorpr.com
FAQ
What is the projected market value for supplements by 2028 according to Prenetics' IM8?
Who are the new additions to IM8's Scientific Advisory Board in March 2025?
What is IM8's Daily Ultimate Essentials supplement designed to do?
Which prestigious institutions are represented on IM8's Scientific Advisory Board?
